The Health Committee's new report has reminded the government of a much-needed pharmacy workforce plan to support recruitment, training, and retention of staff.
The report makes a number of recommendations to optimise workloads across primary care, reduce pressure on general practice and hospitals, and support the integrated
care systems.
It also recognises the potential of pharmacist independent prescribers to support patient care, backed by appropriate supervision, training, and opportunities for
professional development.
RPS England gave evidence to MPs on the Committee at a public hearing in May, highlighting key issues to support the pharmacy workforce.
RPS director for England, Ravi Sharma, said: "Today's report underlines the urgent need for the Government to set out a comprehensive workforce plan for health and
care.
"It rightly recognises that boosting recruitment and retention, supporting staff wellbeing, fostering inclusion and diversity, and investing in education and
training will be crucial to the future of the NHS.
A polio vaccine booster campaign is being launched for almost a million children in London aged between 1 and 9 after confirmation that poliovirus is
spreading in the capital for the first time since the 1980s.
The UK Health Security Agency has identified 116 polioviruses from 19 sewage samples this year in London, after first sending an alert about finding the virus in
June. The levels of poliovirus found and genetic diversity indicated that transmission was taking place in a number of London boroughs, the agency said on Wednesday
(Aug 10).
Health secretary Steve Barclay said: "I recognise parents and guardians will be concerned about the detection of polio in London, however I want to reassure people
that nobody has been diagnosed with the virus and the risk to the wider population is low…
"Vaccines offer the best defence to children, and those around them, so I would encourage families to ensure they are up to date with their routine jabs, and to come
forward for the polio booster as soon as they are contacted by the NHS."
Pharmaceutical giant Bristol Myers Squibb has become the first pharmaceutical company in the UK to be accredited as a 'menopause friendly workplace'.
The accreditation, awarded by an independent panel of judges, recognises employers who put diversity, inclusion and wellbeing at the centre stage of their business.
Bristol Myers Squibb (BMS) said it rung in the changes in recognition of the fact that nearly eight of 10 menopausal women are in work and that this is the fastest
growing demographic in the workforce.
Panel members described BMS UK&I's application as "outstanding" and acknowledged "the huge strides they have made to help normalise the menopause" by fostering an
inclusive culture.
The General Pharmaceutical Council (GPhC) has initiated the evaluation of its five-year strategy for changing the way it manage concerns about pharmacy
professionals. It has urged people to share their experience of fitness to practice.
The evaluation will look at how the strategy has improved the experience of people involved in fitness to practice (those who raise concerns, professionals,
witnesses etc.); impacted the culture amongst pharmacy professionals and their attitudes to openness and honesty; improved the process and made it fairer and
changed perceptions of fitness to practice.
The first phase of the evaluation process will take place from July to September 2023.
The council said: "We are committed to making our ambitions a reality for the benefit of everyone involved and your contribution will help us to make sure patients
and the public continue to be protected while being fair to pharmacy professionals."
In June 2021, GPhC published its five-year strategy- Managing concerns about pharmacy professionals: Guided by its 2030 vision and commitment to equality, diversity
and inclusion, the strategy outlines a programme for change.
In response to new research that revealed inequality in menopause support with 51 per cent of women from black, Asian and minority ethnic backgrounds,
Holland & Barrett, the UK's leading health and wellness retailer, has decided to continue its menopause campaign work to make "every menopause matter".
A quarter of women (26 per cent) from minority ethnic communities say they find it difficult to access menopause support relevant to their specific backgrounds.
Alongside support from Olympian and menopause campaigner, Michelle Griffith Robinson and expert, Meera Bhogal, the retailer is launching several new initiatives
to make its information and support on menopause more inclusive by offering more diverse and personalised advice and content, tailored to different needs.
Almost a third (31 per cent) believe being able to speak to a female healthcare professional of the same ethnicity as them would have made a difference to their
menopause experience. Fifteen per cent go as far as saying that communicating in their native language would have made a positive difference.
Based on these findings, Holland and Barrett is the first retailer to launch a free, multi-language menopause online consultation service. The service will
see trained H&B menopause advisors offering guidance and symptom support in multiple languages, starting with Hindi, Urdu, Gujarati and Punjabi.
NHS England and NHS Improvement (NHSE&I), in association with the Royal Pharmaceutical Society (RPS) and the Association of Pharmacy Technicians UK (APTUK),
has published its first inclusive pharmacy practice (IPP) bulletin, with an overarching ambition "to make community pharmacy a more inclusive environment for all
pharmacy professionals".
The IPP programme will take practical steps to improve the awareness and understanding at all levels of different cultural beliefs and attitudes, according to the
Pharmaceutical Services Negotiating Committee (PSNC).
As a member of the IPP Improving Practice and Engagement Group, PSNC has contributed to this issue of the Bulletin, which focuses on how pharmacy professionals can
help to reduce health inequalities via the detection and prevention of cardiovascular diseases.
The IPP programme, of which the Bulletin forms a part, aims to engage with local communities to help improve their health and reduce inequalities in care -
particularly among those from ethnically diverse and disadvantaged backgrounds.
A group of pharmacists on Saturday (July 2) took part in this year's Pride in London parade, as the annual LGBTQ+ celebration returned to the capital after
three years due to the Covid-19 pandemic.
Those who participated in the march called on the government to ban conversion therapy for all LGBT+ people, reform the Gender Recognition Act, and provide equal
protection for LGBT+ communities against hate crime.
The event which drew a crowd of a million people marked the 50th anniversary since the first ever parade in London in 1972.
Amandeep Doll, head of professional belonging at RPS, said: "It was a privilege to join in the recognition of the diversity of the LGBTQI+ community and our
profession, especially on such a historic occasion. Our group of pharmacists and allies from all parts of the country loved the excitement and buzz of the day."
The Royal Pharmaceutical Society (RPS) England director, Ravi Sharma, has resigned after four years on the job.
He will be leaving the RPS in October to join Luton and Dunstable University Hospital, part of the Bedfordshire Hospitals NHS Foundation Trust group, as head of
pharmacy.
RPS will be commencing the recruitment of a new director for England shortly and in the interim Ravi will be working with Paul Bennett, the RPS CEO, to help in
delivery of key objectives and in the appointment of his successor.
Paul commented: "Ravi has made a significant contribution to the organisation during his time with us. His drive and enthusiasm for advancing the recognition of
the role of the Society itself and of pharmacists and professional practice is probably best reflected by his desire to ensure a real focus on personalised medicines
and his work on equality and diversity, workforce wellbeing, and most recently the development of a new vision for pharmacy in England.
Kailash Deepak Hospital stands tall as the best multispeciality and private hospital in Delhi. Renowned for exceptional medical services, we lead the forefront of healthcare, catering to diverse needs with innovation and expertise. Your trusted destination for superior care in Delhi.
The International Pharmaceutical Federation (FIP) launched a report on pharmacy-led common ailment schemes.
The data was collected from 24 countries, including case studies from nine countries.
It highlighted the growing demand for care models for ageing populations and the increase in chronic non-communicable diseases.
Pharmacists had been managing the stress, including prescribing authority and provision of medicinal treatments.
Paul Sinclair AM, Global President of FIP, said, "I believe this report is both a foundation and a catalyst - a foundation on which FIP and our member
organizations could base initial strategies and a catalyst to drive us to seek even more diverse and comprehensive insights in the future.
Travelling with medical cannabis can be a complex and often confusing experience, given the diverse legal regulations across different countries and states.
Patients who rely on medical cannabis for their wellbeing need to be well-informed and prepared to ensure a smooth and hassle-free travel experience. This
comprehensive guide covers essential aspects, legal considerations, and practical tips for individuals who use medical cannabis and wish to travel.
Know the Laws
The first and most crucial step before travelling with medical cannabis is to understand the laws and regulations of both the departure and destination locations.
Laws regarding medical cannabis use vary significantly from one country, state, or even city to another. Some places have legalised medical cannabis, while others
strictly prohibit its use. Researching and familiarising oneself with the specific regulations of the destination, transit countries, and the home country is
essential.
Travelling Within the Same Country
When travelling within a country where medical cannabis is legal, patients generally need to carry their prescription information issued by a licensed healthcare
provider. It's advisable to keep medical cannabis in its original packaging, clearly labelled with the patient's name, prescribing physician, and dosage instructions.
Carrying a copy of the relevant laws and regulations can also be helpful in case of any inquiries from authorities. What can be easier than carrying around paperwork,
which could get easily damaged or lost during your travels, is to get a medical card that has a unique QR code on it from Releaf Cannabis, which, when scanned, can
present their prescription information digitally - it has revolutionised the way patients manage their healthcare. This eliminates the need for physical documents
and streamlines the process but also ensures the security and confidentiality of sensitive medical information, offering patients a more efficient and organi
When I was asked by fellow independent contractors to join the Review Steering Group (RSG) back in late 2020, I said yes, because I wanted, fundamentally,
to look for some ways to improve both LPCs and PSNC. Through my experiences with Greater Manchester LPC I had seen the sorts of changes that LPCs could make and
the positive impact that those had on local engagement and in allowing us to do more to support contractors: I wanted to help share what we had learned with the
rest of the country. I was pretty sure that the national negotiator could make some positive changes as well.
It took longer than I had hoped. And it was a lot harder than I had imagined - not least because of the extent of some of the divisions within our sector - but
after 15 months of hard work, I'm pleased with where we have got to, and I believe the 37 changes being proposed will help all contractors.
Consensus is not a sexy word. It is not something that fires up our imaginations or that we put on our list of key work objectives for the year. It is also not something that might come naturally to us as independent contractors. But consensus is something that matters. It is the thing that allows us, as a vibrant and diverse group of businesses, to see beyond our differences and to fight together for outcomes that benefit every single one of us.
Consensus is also the thing that the RSG has been relentlessly focused on throughout its work, and it's at the heart of what will give our LPCs and PSNC a stronger voice for community pharmacy in the future.
Walgreens Boots Alliance has announced the launch of its new clinical trials business that aims to use patient data from its pharmacies to help drive up
recruitment in studies conducted by drugmakers.
With patient recruitment and enrollment remain key challenges in clinical trials, further exacerbated by the COVID-19 pandemic, the company said it can proactively
match diverse patient populations to trials across a range of disease areas based on race, gender, socioeconomic status and location with its patient reach and
access to an extensive foundation of pharmacy and patient-authorised clinical data.
The Boots owner also believes that by leveraging a tech-enabled approach to patient identification and creating a large registry of clinical trial participants,
the company will be able to reduce the time it takes to match eligible patients to clinical trials.
"Walgreens trusted community presence across the nation, combined with our enterprise-wide data and health capabilities, enables us to pioneer a comprehensive
solution that makes health options, including clinical trials, more accessible, convenient and equitable," said Ramita Tandon, chief clinical trials officer,
Walgreens.
The Association of Independent Multiple Pharmacies (AIMp) has appointed David Vanns as its non-executive Chairman following the retirement of its long serving
Chair Peter Cattee. Vanns will take up the role from April 2023.
Cattee, one of the co-founders of AIMp took up the role as its Chairman in 2000. He is also a non-CCA representative on the PSNC. Despite retiring as chairman Cattee
will remain on the AIMp board.
Commenting on his retirement Cattee said: "It's been my great good fortune to work with almost all of the owners of pharmacy groups throughout England, Scotland and
Wales over the years and many other talented people throughout the sector. It's been during a period of increasing consolidation, something which our own business
has reflected, and the original founders and Board members Yakub Patel, Kirit Patel, Steve Williams and David Vanns have all been instrumental in shaping pharmacy
negotiations to better reflect the views of our natural constituency - pharmacy group owners.
A spokesperson for AIMp said: "We thank Peter for his services and dedication to AIMp throughout the years. Our organisation has grown to be a diverse and dynamic
organisation representing and supporting pharmacy groups of all sizes, small and large. Our main identity and what unites us in AIMp, irrespective of the size of
the pharmacy group, is being Independents, and we are very proud of our identity. We look forward to continuing our work in representing and supporting our members
in the best way possible."
Your gut, often referred to as your "second brain," plays a crucial role in your overall health and well-being. From digestion to immunity, mood
regulation to nutrient absorption, the gut impacts various aspects of our daily lives. With increasing awareness of the gut-brain connection, prioritizing
gut health has become a cornerstone of holistic wellness. In this article, we explore effective strategies to support and nurture your gut, empowering you to
enhance your quality of life through simple yet impactful practices.
Nourish with Probiotic-Rich Foods
The gut microbiome, comprised of trillions of bacteria, fungi, and other microorganisms, is a dynamic ecosystem essential for digestive health and immune function.
To maintain a healthy balance of gut flora, incorporating probiotic-rich foods into your diet is paramount. Yogurt, kefir, kimchi, sauerkraut, and kombucha are
excellent sources of beneficial bacteria that promote gut diversity and resilience. These fermented foods not only replenish your gut with probiotics but also
provide essential nutrients and enzymes vital for optimal digestion. By regularly including probiotic foods in your meals, you can foster a thriving gut microbiome,
fortifying your body's natural defenses against pathogens and inflammation.
Kamila Hawthorne, the chair of the Royal College of General Practitioners (RCGP) Council, was honoured with the GG2 Woman of the Year Award at the annual
GG2 Leadership and Diversity Awards, held at the Park Plaza Hotel on Tuesday, 5 March.
Hawthorne has been a practitioner and a mentor to young GPs for almost 35 years, and has led pioneering research projects focusing on health inequalities,
diabetes and heart disease. She has been recognised twice as GP of the Year for her work with minority ethnic communities.
Professor Kiran Patel, Group Chief Medical Officer at University Hospitals Birmingham NHS Foundation Trust, was named the GG2 Man of the Year Award.
Apart from being a sought-after cardiologist and consultant, Patel also possesses a wealth of experience in managerial roles. He has done a lot of work in
addressing health inequalities, and notably, in 2020, he prescribed the very first COVID-19 vaccine.
The hybrid professional and leadership session underscores the Sigma Conference's significance in offering hope and inspiration to its delegates. This
pioneering venture unfolds following meticulous planning, months of deliberation, and the collaboration of experts from various health disciplines across the UK.
This session, rich in diversity and expertise, aims to elevate the role of community pharmacy in the ever-evolving landscape of the NHS.
It comprises three key components and delves into multi-professional collaboration, insights from NHS Chief Professional Officers from the four devolved nations
complimented by the Royal College of Nursing Directorate Wales, and the evolving landscape of Pharmacy Professional Leadership.
Multi-Professional Collaboration: Breaking Boundaries
The crux of this ground-breaking session lies in appreciating and fostering greater multi-professional collaboration to set the stage for a thought-provoking
session on how community pharmacy can be recognised as an important cog in the wheel of an integrated NHS. This convergence creates a dynamic platform for community
pharmacy to form wider partnerships and explore opportunities, particularly with the recently launched NHS Pharmacy First Service.
In a bid to bolster the educational experience for undergraduate pharmacy students across London, Kingston University has embarked on a groundbreaking
project in collaboration with University College London and King's College London.
This initiative, fueled by a substantial £1.5 million investment from National Health Services England (NHSE), aims to elevate the quality and consistency of
pharmacy placements throughout the capital for new pharmacy entrants.
The project is designed to address the evolving standards set forth by the General Pharmaceutical Council (GphC), ensuring that newly-trained pharmacists
are well-prepared to meet the demands of their profession.
By standardizing and expanding pharmacy placements, the three universities seek to provide students with a comprehensive and diverse range of "experiential
learning opportunities".
Professor Mahendra Patel OBE, CEO of the Oxford University Centre for Research Equity (CfRE), has been appointed as an independent expert member of the UK
Pharmacy Professional Leadership Advisory Board.
The newly established Board comprises nine independent expert members (IEMs) with outstanding leadership capabilities, who were appointed through open recruitment,
ensuring a "broad, balanced, and diverse" representation.
Sir Hugh Taylor KCB, the Independent Chair of the Board, and the UK Chief Pharmaceutical Officers (CPhOs) - Andrew Evans (Wales), Cathy Harrison (Northern Ireland),
Alison Strath (Scotland), and David Webb (England) - announced the appointment of IEMs in an open letter to the UK pharmacy professions.
"Bringing a wealth of experience and expertise, they will play a pivotal role in the Board's work to deliver an exciting vision through supporting a new and dynamic
phase of collaboration," the CPhOs said.
As the CEO of CfRE, Professor Patel spearheads efforts aimed at addressing inequalities in healthcare.
In a move towards greater diversity and inclusivity, the National Pharmacy Association (NPA) has welcomed three accomplished women to its board of key members.
Aisling O'Brien, Sukhi Basra, and Sehar Shahid-who is the youngest member- have joined the board, marking a significant step in the organisation's commitment
to equality and representation.
The announcement, made on the occasion of the International Women's Day, by chief executive, Paul Rees MBE via X reflects the organisation's dedication to
celebrating and empowering women in the pharmacy profession.
Sukhi Basra, the inaugural female board member since last April, adds a valuable dimension to the NPA. With her role as a Community Pharmacy KCW committee
member and her experience in clinical pharmacy spanning over 25 years, she brings a wealth of knowledge and a distinctive viewpoint.